Lacosamide Medical Valley 100 mg נורווגיה - נורבגית - Statens legemiddelverk

lacosamide medical valley 100 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 100 mg

Lacosamide Medical Valley 50 mg נורווגיה - נורבגית - Statens legemiddelverk

lacosamide medical valley 50 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 50 mg

Lacosamide Medical Valley 150 mg נורווגיה - נורבגית - Statens legemiddelverk

lacosamide medical valley 150 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 150 mg

Lacosamide Medical Valley 200 mg נורווגיה - נורבגית - Statens legemiddelverk

lacosamide medical valley 200 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 200 mg

Drovelis האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - sex hormoner og modulatorer av genital systemet, - oral contraceptive.

Topogyne 400 mikrog נורווגיה - נורבגית - Statens legemiddelverk

topogyne 400 mikrog

exelgyn - misoprostol - tablett - 400 mikrog

Vimpat 100 mg נורווגיה - נורבגית - Statens legemiddelverk

vimpat 100 mg

orifarm as - lakosamid - tablett, filmdrasjert - 100 mg

Vimpat 150 mg נורווגיה - נורבגית - Statens legemiddelverk

vimpat 150 mg

orifarm as - lakosamid - tablett, filmdrasjert - 150 mg

Vimpat 200 mg נורווגיה - נורבגית - Statens legemiddelverk

vimpat 200 mg

orifarm as - lakosamid - tablett, filmdrasjert - 200 mg

Lacosamide Adroiq האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.